BACKGROUND AND PURPOSE: Mitochondrial aldehyde dehydrogenase (ALDH-2) has been shown to provide a pathway for bioactivation of organic nitrates and to be prone to desensitization in response to highly potent, but not to less potent, nitrates. We therefore sought to support the hypothesis that bioactivation by ALDH-2 critically depends on the number of nitrate groups within the nitrovasodilator. EXPERIMENTAL APPROACH: Nitrates with one (PEMN), two (PEDN; GDN), three (PETriN; glyceryl trinitrate, GTN) and four (pentaerithrityl tetranitrate, PETN) nitrate groups were investigated. Vasodilatory potency was measured in isometric tension studies using isolated aortic segments of wild type (WT) and ALDH-2-/- mice. Activity of the cGMP-dependent kinase-I (reflected by levels of phosphorylated VAsodilator Stimulated Phosphoprotein, P-VASP) was quantified by Western blot analysis, mitochondrial dehydrogenase activity by HPLC. Following incubation of isolated mitochondria with PETN, PETriN-chromophore and PEDN, metabolites were quantified using chemiluminescence nitrogen detection and mass spectrometry. KEY RESULTS: Compared to WT, vasorelaxation in response to PETN, PETriN and GTN was attenuated about 10fold in ALDH-2-/- mice, identical to WT vessels preincubated with inhibitors of ALDH-2. Reduced vasodilator potency correlated with reduced P-VASP formation and diminished biotransformation of the tetranitrate- and trinitrate-compounds. None of these findings were observed for PEDN, GDN and PEMN. CONCLUSIONS AND IMPLICATIONS: Our results support the crucial role of ALDH-2 in bioactivating highly reactive nitrates like GTN, PETN and PETriN. ALDH-2-mediated relaxation by organic nitrates therefore depends mainly on the number of nitrate groups. Less potent nitrates like PEDN, GDN and PEMN are apparently biotransformed by other pathways.
BACKGROUND AND PURPOSE: Mitochondrial aldehyde dehydrogenase (ALDH-2) has been shown to provide a pathway for bioactivation of organic nitrates and to be prone to desensitization in response to highly potent, but not to less potent, nitrates. We therefore sought to support the hypothesis that bioactivation by ALDH-2 critically depends on the number of nitrate groups within the nitrovasodilator. EXPERIMENTAL APPROACH: Nitrates with one (PEMN), two (PEDN; GDN), three (PETriN; glyceryl trinitrate, GTN) and four (pentaerithrityl tetranitrate, PETN) nitrate groups were investigated. Vasodilatory potency was measured in isometric tension studies using isolated aortic segments of wild type (WT) and ALDH-2-/- mice. Activity of the cGMP-dependent kinase-I (reflected by levels of phosphorylated VAsodilator Stimulated Phosphoprotein, P-VASP) was quantified by Western blot analysis, mitochondrial dehydrogenase activity by HPLC. Following incubation of isolated mitochondria with PETN, PETriN-chromophore and PEDN, metabolites were quantified using chemiluminescence nitrogen detection and mass spectrometry. KEY RESULTS: Compared to WT, vasorelaxation in response to PETN, PETriN and GTN was attenuated about 10fold in ALDH-2-/- mice, identical to WT vessels preincubated with inhibitors of ALDH-2. Reduced vasodilator potency correlated with reduced P-VASP formation and diminished biotransformation of the tetranitrate- and trinitrate-compounds. None of these findings were observed for PEDN, GDN and PEMN. CONCLUSIONS AND IMPLICATIONS: Our results support the crucial role of ALDH-2 in bioactivating highly reactive nitrates like GTN, PETN and PETriN. ALDH-2-mediated relaxation by organic nitrates therefore depends mainly on the number of nitrate groups. Less potent nitrates like PEDN, GDN and PEMN are apparently biotransformed by other pathways.
Authors: M Oelze; H Mollnau; N Hoffmann; A Warnholtz; M Bodenschatz; A Smolenski; U Walter; M Skatchkov; T Meinertz; T Münzel Journal: Circ Res Date: 2000-11-24 Impact factor: 17.367
Authors: K Kitagawa; T Kawamoto; N Kunugita; T Tsukiyama; K Okamoto; A Yoshida; K Nakayama; K Nakayama Journal: FEBS Lett Date: 2000-07-07 Impact factor: 4.124
Authors: A Mülsch; M Oelze; S Klöss; H Mollnau; A Töpfer; A Smolenski; U Walter; J P Stasch; A Warnholtz; U Hink; T Meinertz; T Münzel Journal: Circulation Date: 2001-05-01 Impact factor: 29.690
Authors: Andrei L Kleschyov; Matthias Oelze; Andreas Daiber; Yale Huang; Hanke Mollnau; Eberhard Schulz; Karsten Sydow; Birgit Fichtlscherer; Alexander Mülsch; Thomas Münzel Journal: Circ Res Date: 2003-10-09 Impact factor: 17.367
Authors: S Schuhmacher; E Schulz; M Oelze; A König; C Roegler; K Lange; L Sydow; T Kawamoto; P Wenzel; T Münzel; J Lehmann; A Daiber Journal: Br J Pharmacol Date: 2009-06-25 Impact factor: 8.739
Authors: Monica Lisi; Matthias Oelze; Saverio Dragoni; Andrew Liuni; Sebastian Steven; Mary-Clare Luca; Dirk Stalleicken; Thomas Münzel; Franco Laghi-Pasini; Andreas Daiber; John D Parker; Tommaso Gori Journal: Clin Res Cardiol Date: 2012-06 Impact factor: 5.460
Authors: Matthias Oelze; Maike Knorr; Richard Schell; Jens Kamuf; Andrea Pautz; Julia Art; Philip Wenzel; Thomas Münzel; Hartmut Kleinert; Andreas Daiber Journal: J Biol Chem Date: 2011-01-20 Impact factor: 5.157
Authors: Philip Wenzel; Swenja Schuhmacher; Joachim Kienhöfer; Johanna Müller; Marcus Hortmann; Matthias Oelze; Eberhard Schulz; Nicolai Treiber; Toshihiro Kawamoto; Karin Scharffetter-Kochanek; Thomas Münzel; Alexander Bürkle; Markus Michael Bachschmid; Andreas Daiber Journal: Cardiovasc Res Date: 2008-07-02 Impact factor: 10.787
Authors: Matteo Beretta; Antonius C F Gorren; M Verena Wenzl; Robert Weis; Michael Russwurm; Doris Koesling; Kurt Schmidt; Bernd Mayer Journal: J Biol Chem Date: 2009-11-11 Impact factor: 5.157